Andy Sassine, Chief Financial Officer at Arcturus Therapeutics Holdings Inc. (ARCT), sold 50,000 shares at $32.03 ($1.6M) on 2024-06-12, disclosed to the SEC on 2024-06-14.
Open-market sale of $1.6M ARCT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ICAD | SELL | 2022-01-11 | $123K | — | Filing → |
| ICAD | SELL | 2021-12-08 | $140K | — | Filing → |
| ICAD | SELL | 2021-11-10 | $212K | — | Filing → |